Lake Street Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga Newsdesk www.benzinga.com Positive 57.2%

Neg 0% Neu 0% Pos 57.2%

Lake Street initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces Price Target of $32.

Comments

No comments yet. Be the first!